Home » Topics » BioWorld Science

BioWorld Science
RSS

Anti-TNF strategy in MS treatment should be reconsidered

Jan. 28, 1998

Rate-independent profile of antiarrhythmic agent suggests improved therapeutic potential

Jan. 28, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Phenylglycine derivatives with mGluR-antagonist activity disclosed by Lilly

Jan. 28, 1998

Flavopiridol analogues as inhibitors of cyclin-dependent kinases

Jan. 28, 1998

Antitumor and antiviral distamycin derivatives from Pharmacia & Upjohn

Jan. 28, 1998

Indole endothelin antagonists prepared at Pfizer

Jan. 28, 1998

New AIDS therapies in development in Korea

Jan. 28, 1998

PKC modulators for proliferative disorders described by Georgetown U.

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...